Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New balloon device aims to ease stomach blockages without surgery

NCT ID NCT07161856

Symptom relief Sponsor: Changhai Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study compares a new balloon-assisted technique to the standard water-injection method for creating a stomach-to-intestine bypass in people with gastric outlet obstruction. The blockage, often caused by advanced cancer, leads to nausea, vomiting, and malnutrition. The new approach aims to shorten procedure time, reduce fluid use, and improve safety. About 272 adults who cannot have surgery or stents will take part across multiple centers.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
novel single-balloon-assisted device for EUS-guided gastroenterostomy
What this could lead to
If successful, this new technique could offer a safer, faster, and less invasive way to relieve gastric outlet obstruction, improving quality of life for patients who cannot have surgery.
What could go wrong
This is an early-stage trial with 272 participants, and the new device may not prove safer or more effective than the current method. The procedure still carries risks like bleeding or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 272 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2025

An estimate. Start dates often move.

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ranges from 18 to 80 years old * GOO patients caused by all reasons (including benign diseases such as ulcers or malignant tumors) * Not suitable for or cannot tolerate surgical operations and endoscopic intestinal stent implantation * There are no absolute contraindications for EUS-GE * Signed informed consents Exclusion Criteria: * Pregnant and lactating women * Unable or refused to provide informed consents * Patients with cognitive impairment, aphasia, mental disorders, or other conditions that may affect the patient's cooperation * Patients with endoscopic contraindications, anesthesia contraindications, digestive tract perforation or abdominal cavity infection * The tumor invades the duodenum or the upper segment of the jejunum Individuals whom the investigator deems unsuitable for participation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gastric outlet obstruction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

pyloric stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gastric outlet obstruction

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.